CD34 and acute myeloid leukemia: Using RT-qPCR, survivin was found to be significantly up-regulated in primary CD34+ cells from AML patients (89.3%, 50/56) when compared with their corresponding CD34- counterparts (P < 0.05, Figure 1F).